Improving outcomes with early and intensive metabolic control in patients with type 2 diabetes: a long-term modeling analysis of clinical and cost outcomes in Italy
Authors
Jonathan Rachman
Rosanna Raiola
Marco Orsini Federici (ORCID: https://orcid.org/0000-0002-4675-0654)
William J. Valentine (ORCID: https://orcid.org/0000-0003-4844-6813)
Kristina S. Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
Improving outcomes with early and intensive metabolic control in patients with type 2 diabetes: a long-term modeling analysis of clinical and cost outcomes in Italy
Jonathan Rachman, Rosanna Raiola, Marco Orsini Federici, William J. Valentine et al.
Citations
2 citations
Journal
Journal of Diabetes & Metabolic Disorders
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
2.59
article
Improving outcomes with early and intensive metabolic control in patients with type 2 diabetes: a long-term modeling analysis of clinical and cost outcomes in Italy
Jonathan Rachman, Rosanna Raiola, Marco Orsini Federici, William J. Valentine, Kristina S. Boye, M. Guidi, Pierluca Arietti, Arianna Avitabile
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Diabetes & Metabolic DisordersVol. 24(1)
Institutions
Eli Lilly (United States) (US), Eli Lilly (United Kingdom) (GB), BAK Basel Economics (Switzerland) (CH), Eli Lilly (Italy) (IT)